600 related articles for article (PubMed ID: 32858231)
1. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
[No Abstract] [Full Text] [Related]
3. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
[TBL] [Abstract][Full Text] [Related]
4. The value of clinical parameters in predicting the severity of COVID-19.
Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictive value of hypocalcemia in severe COVID-19 patients.
Liu J; Han P; Wu J; Gong J; Tian D
J Infect Public Health; 2020 Sep; 13(9):1224-1228. PubMed ID: 32622796
[TBL] [Abstract][Full Text] [Related]
6. The value of PCT, IL-6, and CRP in the early diagnosis and evaluation of COVID-19.
Zhou YZ; Teng XB; Han MF; Shi JF; Li CX; Zhang XH; Hou DY; Yang LL
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):1097-1100. PubMed ID: 33577066
[TBL] [Abstract][Full Text] [Related]
7. [Predictive effect of combined procalcitonin, interleukin-6 and antithrombin III on the severity and prognosis of patients with sepsis].
Cao Z; Wu M; Li Y; Ding R; Zhang J; Liu L; Ren H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Oct; 35(10):1033-1038. PubMed ID: 37873706
[TBL] [Abstract][Full Text] [Related]
8. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin and C-reactive protein perform better than the neutrophil/lymphocyte count ratio in evaluating hospital acquired pneumonia.
Zheng N; Zhu D; Han Y
BMC Pulm Med; 2020 Jun; 20(1):166. PubMed ID: 32527243
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
Xu Y; Qian Y; Gu Q; Tang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
[TBL] [Abstract][Full Text] [Related]
11. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis.
Soraya GV; Ulhaq ZS
Med Clin (Barc); 2020 Aug; 155(4):143-151. PubMed ID: 32586670
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].
Zhao Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287
[TBL] [Abstract][Full Text] [Related]
13. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
[No Abstract] [Full Text] [Related]
14. Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study.
Gong J; Dong H; Xia QS; Huang ZY; Wang DK; Zhao Y; Liu WH; Tu SH; Zhang MM; Wang Q; Lu FE
BMC Infect Dis; 2020 Dec; 20(1):963. PubMed ID: 33349241
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
[TBL] [Abstract][Full Text] [Related]
17. Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19.
Xu Y; Wang N; Shen X; Liu X; Liu H; Liu Y
Clin Exp Med; 2023 Nov; 23(7):3719-3728. PubMed ID: 37310657
[TBL] [Abstract][Full Text] [Related]
18. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
[TBL] [Abstract][Full Text] [Related]
19. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
20. The role of C-reactive protein, procalcitonin, interleukin-6 and neutrophil / lymphocyte ratio as a laboratory biomarker in COVID-19.
Al-Juboori RSF; Al-Bayaa YJ
Egypt J Immunol; 2024 Apr; 31(2):93-101. PubMed ID: 38615266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]